-
Search Underway for 'Dooars Rani' Tigress After Second Escape from Buxa Tiger Reserve
-
Teatro Mayor Unveils 152-Performance 2027 Season Highlighting Beethoven and García Márquez
-
The Dilemma of Recording Live Music: Preserving Memories vs. Being Present
-
Rutgers Defeats NJIT 101-64 Behind Francis and Mark Scores
-
Protagenic Therapeutics Announces Private Placement of Up to $5 Million to Advance PT00114 into Its First U.S. Clinical Trial in Generalized Anxiety Disorder
-
Healixa's FrostPulse(TM) Technology Solves a Major Roadblock to Data Center Growth: Cooling Without the Water Burden
-
Route1 Announces 2026 Annual Meeting Results
-
NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
-
Ethur Takes On Hiring Fraud With Facial Biometrics Identity Checks and Connected Payroll and Bank Data
-
PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
-
Green Leaf Innovations (OTC: GRLF) Meets OTCID Disclosure Requirements Following Profitable Q2 2026 Results
-
Valion Bio Reinforces Commitment to American Troops; Discusses Entolimod with Attendees at RW Baird's National Security Conference
-
XCF Global Hosts USDA at New Rise Renewables Reno as Facility Surpasses 4.4 Million Gallons Since Restart
-
Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets
-
AmeriLife Welcomes Finance Veteran Richard Dziadzio as Chief Financial Officer; Names Jim Quinn President & Chief Transformation Officer
-
Trifecta Gold Reports 2026 Exploration Results from the Liam and Lois Projects, Tombstone Gold Belt, Yukon
-
Irving Resources Reports on Drilling in Yamagano Mining Right at the Yamagano Joint Venture, Kyushu, Japan
-
NiobiumX Mining Reports Results of Ground Radiometric Survey at Shipshaw, Maps Two Distinct Radiometric Signatures Across the Core Claims, and Moves to a High-Resolution Airborne Survey of the Full 2,686-Hectare Package
-
BlackBerry to Participate in Upcoming Investor Conferences
-
Christmas Day Shifts More than Double as Americans Return to In-Person Holiday Celebrations
-
THIEAUDIO Introduces Clairvoyance MKII: The Evolution of a Signature Sound
-
Fulcrum Metals PLC Announces Publication of Updated Investor Presentation
-
Guardian Metal Resources PLC Announces Proposed Spin-Out of Non-Tungsten Projects
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 11
-
Fulcrum Metals PLC Announces New Critical Mineral Recoveries Expand Potential
-
6 Pieces of Furniture Worth Investing In
-
5E Advanced Materials to Host Fiscal First Quarter 2027 Earnings Conference Call on November 17, 2026
-
Sequoia Backs Microsoft Veterans' Edelbyte with $70M to Challenge Data Infrastructure Giants
-
Price Benowitz Earns 2027 Best Law Firm Recognition; 18 Attorneys Recognized by Best Lawyers
-
DaBella Honors More Than 200 Veteran Employees Nationwide This Veterans Day
-
ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
-
Resilient Energy Inc. (OTCID:RENI) Closes Acquisition of Mid River Midstream; Adds 12 Texas SWD Wells and $25M in Assets
-
SMX Expands Technology Portfolio With AI-Powered Scientific Intelligence Platform
-
LA Kush Cake Strain Guide Reviews Genetics and Historical Potency Data
-
Solid Aluminum, Deep Thock and 75% Compact Layout: Meet the Epomaker Galaxy75 Mechanical Keyboard
-
Who Is the Best Facial Feminization Surgeon?
-
CLS Health Advances Construction on New Webster Surgical Campus, Expanding Access to Care in Clear Lake Area
-
Cognitum One Launches Cognitum Spaces, the Governed System of Record for Physical Sites That Gives Enterprise AI Agents Trusted Real-World Context
-
OneMeta Provides Real-Time AI Translation for 2026 G20 Interfaith Forum Summit
-
Cosmos Health Provides U.S. E-Commerce Update for October 2026: Monthly Subscription Value Reaches $1.83 Million, Approximately $22 Million Annualized
-
LiveOne (Nasdaq: LVO) to Report Second Quarter Fiscal 2027 Financial Results on November 12, 2026
-
Arrive AI Announces Strategic Investment in Ottonomy to Accelerate Autonomous Delivery Network Expansion
-
Aptevo Therapeutics Announces Exercise of Existing Warrants for $3.0 Million Gross Proceeds
-
Healthcare Leaders Identify Priorities for Agentic AI Adoption in 2027-2028 - Black Book
-
TAMKO and Kansas City Chiefs Announce 2026 Operation Rooftop Recipient
-
Marketing Worldwide Corporation (OTC:MWWC) Announces 1-for-350 Reverse Stock Split Effective November 11, 2026
-
Patriot Software Adds Performance Reviews to Patriot HR
-
Thukukile Zuma Resigns from ANC Johannesburg Leadership Amid Disciplinary Dispute
-
Russia Orders 100,000 Kometa Modules to Counter Ukrainian Electronic Warfare
-
CM Mohan Yadav Meets Bohra Spiritual Leader to Discuss Simhastha 2028 and Development
Texas federal judge halts US approval of abortion pill
A conservative federal judge in the state of Texas halted US approval of the abortion pill mifepristone on Friday, but paused implementation for a week to give federal authorities time to appeal.
The suit against the Food and Drug Administration is the latest step in the campaign to win a total ban on abortion following a landmark Supreme Court ruling last year. It takes aim at a pill involved in 53 percent of all abortions in the United States, or more than half a million every year.
"FDA's approval of mifepristone is hereby STAYED," Judge Matthew Kacsmaryk wrote in his decision, adding that the court was also halting "applicability of this opinion and order for seven (7) days."
While the FDA has never been challenged like this before on its approval of a drug that has proven safe and effective, the plaintiffs -- a coalition of anti-abortion groups -- counted on being able to win a national freeze on distribution of mifepristone.
Presiding over the case in federal court in Amarillo, Texas is Kacsmaryk, who was appointed to the bench by Republican former president Donald Trump and confirmed by the Senate in 2019.
The judge is a conservative Christian with a personal history of opposition to abortion and a court record of favoring right-wing causes.
The case landed in his court via what critics call "judge-shopping," in which plaintiffs take legal action in a district where the judge has a history of rulings that support their case.
Federal judges in the United States have a right to issue rulings that carry national legal force.
Democratic politicians were quick to react on social media.
"This ruling opens a new door to politicizing medicine," New York Governor Kathy Hochul posted on Twitter. "Extremists will not stop at stripping away abortion rights."
Massachusetts Senator Elizabeth Warren posted that "because of today's lawless ruling, women could lose access to a safe and legal medication they've relied on for decades."
One component of a two-drug regimen used for medication abortion, mifepristone can be used in the United States through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
While abortion care has halted in more than a dozen states after the Supreme Court overturned the long-established constitutional right last June, it is still legal in dozens more.
T.Ward--AMWN